KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Receivables - Other (2017 - 2025)

Historic Receivables - Other for Emergent BioSolutions (EBS) over the last 9 years, with Q3 2025 value amounting to $19.3 million.

  • Emergent BioSolutions' Receivables - Other rose 52.08% to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.3 million, marking a year-over-year increase of 52.08%. This contributed to the annual value of $19.6 million for FY2024, which is 6186.77% down from last year.
  • As of Q3 2025, Emergent BioSolutions' Receivables - Other stood at $19.3 million, which was up 52.08% from $22.9 million recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Receivables - Other high stood at $82.5 million for Q2 2024, and its period low was $19.2 million during Q3 2024.
  • In the last 5 years, Emergent BioSolutions' Receivables - Other had a median value of $51.6 million in 2021 and averaged $48.0 million.
  • Its Receivables - Other has fluctuated over the past 5 years, first soared by 9136.21% in 2021, then tumbled by 7224.24% in 2025.
  • Over the past 5 years, Emergent BioSolutions' Receivables - Other (Quarter) stood at $51.6 million in 2021, then grew by 10.85% to $57.2 million in 2022, then dropped by 10.14% to $51.4 million in 2023, then crashed by 61.87% to $19.6 million in 2024, then fell by 1.53% to $19.3 million in 2025.
  • Its last three reported values are $19.3 million in Q3 2025, $22.9 million for Q2 2025, and $30.9 million during Q1 2025.